Skip to main content
. 2012 Feb 24;12:10. doi: 10.1186/1472-6947-12-10

Table 1.

Number of positive, neutral and negative impacts by study for the six areas

Topic Areas Positive (%) Neutral
(%)
Negative
(%)
Total
Controlled
 Prescribing Support 3 (37.5) 4 (50.0) 1 (12.5) 8
 Disease Management 4 (57.1) 2 (28.6) 1 (100.0) 7
 Clinical Documentation 1 (20.0) 2 (40.0) 2 (40.0) 5
 Work Practice 4 (80.0) 1 (20.0) 0 (0.0) 5
 Preventive Care 1 (33.3) 1 (50.0) 0 (0.0) 2
 Patient-Physician Interaction 0 (0.0) 0 (0.0) 0 (0.0) 0
 Sub-total 13 (48.1) 10 (37.0) 4 (14.8) 27
Descriptive
 Prescribing Support 1 (100.0) 0 (0.0) 0 (0.0) 1
 Disease Management 0 (0.0) 0 (0.0) 0 (0.0) 0
 Clinical Documentation 0 (0.0) 0 (0.0) 1 (100.0) 1
 Work Practice 5 (55.6) 1 (11.1) 3 (33.3) 9
 Preventive Care 1 (100.0) 0 (0.0) 0 (0.0) 1
 Patient-Physician Interaction 2 (50.0) 2 (50.0) 0 (0.0) 4
 Sub-total 9 (56.3) 3 (18.8) 4 (25.0) 16
Combined
 Prescribing Support 4 (44.4) 4 (44.4) 1 (11.1) 9
 Disease Management 4 (57.1) 2 (28.6) 1 (14.3) 7
 Clinical Documentation 1 (16.7) 2 (33.3) 3 (50.0) 6
 Work Practice 9 (64.3) 2 (14.3) 3 (21.4) 14
 Preventive Care 2 (66.7) 1 (33.3) 0 (0.0) 3
 Patient-Physician Interaction 2 (50.0) 2 (50.0) 0 (0.0) 4
Total* 22 (51.2) 13 (30.2) 8 (18.6) 43

*Odds ratios between controlled and descriptive studies are not significant